Skip to main content
. Author manuscript; available in PMC: 2015 Aug 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2014 May 4;20(8):1089–1103. doi: 10.1016/j.bbmt.2014.04.028

Figure 3. Anti-CD20 mAb Treatment Prevents Production of Serum Autoantibodies Against Skin, Salivary Gland, and Lung.

Figure 3

(A–B) Representative photographs (original magnification ×100) of (A) Rag-2−/− BALB/c and (B) Rag-2−/− DBA/2 skin, salivary gland, and lung tissues with GVHD recipient serum autoantibodies from days 7, 15, 25 and 100 after HCT are shown. DAPI staining is shown in blue, and autoantibody staining is shown in green. One representative staining is shown from four mice per group per time point. Average integrated optical density (OD) is shown of serum autoantibody staining from four mice per group per timepoint.